Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim ...

But real lightning would have struck infrequently—and mostly in open ocean, where organic compounds would have quickly ...

Merger Completion: On August 15, 2024, Silexion completed its business combination with Moringa Acquisition Corp, becoming a publicly traded company on Nasdaq under the ticker “SLXN.” This strategic ...

Myotonic Dystrophy Type 1 (DM1) is the most common adult-onset form of muscular dystrophy and a condition that severely affects multiple organs ...

The “warm” data in the middle, such as your old photos, can take a few seconds to retrieve. Most data is cold, and a lot of ...

New RNA-based active agents reliably protect plants against the Cucumber mosaic virus (CMV), the most common virus in agriculture and horticulture ...

Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators ...

Avidity Biosciences Inc. says will submit an application for accelerated approval to the FDA for del-zota before the end of ...

It's Inno Madness time! Inno Madness is our friendly, bracket-style challenge where readers vote to advance companies based ...

This summit offers valuable insights into key issues like productivity, decarbonisation, workforce development, and safety, ...

D-Wave Quantum Inc. ("D-Wave" or the "Company"), a leader in quantum computing systems, software, and services, today announced that it has published a new research paper introducing a novel ...

SCIENTISTS have found a pill that offers ‘100 per cent protection’ against Ebola – sparking hopes of eradicating the deadly ...